Ealia Khosh Kish, Arman Zereshkian, Manjula Maganti, Patrick Veit-Haibach, Antonio Finelli, Neil Eric Fleshner, John Trachtenberg, Nathan Perlis, Alejandro Berlin, Andrew Bayley, Charles Catton, Peter W. M. Chung, Padraig Warde, Sheeraz Ali, Vikaash Kumar, Esmail Mutahar Al-Ezzi, Nazanin Fallah-Rad, Srikala S. Sridhar, Di Maria Jiang. "Impact of duration of bone-targeting agent on adverse events (AEs) and skeletal-related events (SRE) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223): Real-world experience from Princess Margaret Cancer Centre (PM).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e17052